In in vivo studies, the loss of ADCK4 led to reduced survival rates and the development of severe focal segmental glomerulosclerosis (FSGS), a condition marked by glomerular scarring, podocyte damage, and progressive kidney failure [16,17,27,29,50,69,70]. This evidence concerns the gene COQ8B and focal segmental glomerulosclerosis.